Professor Alistair McGuire

Professor Alistair McGuire

Head of Department, Professor of Health Economics

Department of Health Policy

020 7955 6375
Room No
COW 2.02
Office Hours
Friday 16.00-17.00 (MT); Tuesday 16:00-17:00 (LT); Other times available via email appointment
Connect with me

Key Expertise
cost-effectiveness analysis, economic evaluation

About me

Professor Alistair McGuire is Head of Department and Chair of Health Economics at the Department of Health Policy. Prior to this he was Professor of Economics at City University, London after being a tutor in Economics at the University of Oxford. Professor McGuire has also been a Visiting Professor at Harvard University, the University of Sydney, the University of York, and the Universitat Pompeu Fabra, Barcelona.

He has acted as an advisor to a number of governments and governmental bodies, including the United Kingdom government, the UK Competition Commission, the UK Medical Research Council (MRC), the German Institut fur Qualität Wirtschaftlichkeit im Gesundheitswesen (IQWiG), as well as for a number of international bodies (including the World Bank, the WHO, and the IMF) and pharmaceutical and health care insurance companies. 

Professor McGuire has pursued an interest in the economics of health care for over thirty years. His research cover all topics in health economics, including international comparisons, economics of the hospital, public/private sector interface, cost-effectiveness analysis of health technologies, and health economics alongside clinical trials. He also has extensive teaching experience and has written numerous books, articles and reports on this. He has been involved in a number of major clinical trials as the lead health economist.


HP423 Advanced Health Economics
HP4A4E Health Economics

Expertise Details

comparative effectiveness research; cost-effectiveness analysis; economic evaluation; pharmaeconomics; health economics; health services research

My research

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2


Author(s) Sue Philpott, Maria Raikou, Ranjit Manchanda, Michelle Lockley, Naveena Singh, Malcolm Scott, D. Gareth Evans, Julian Adlard, Munaza Ahmed, Richard Edmondson, Emma Roisin Woodward, Athena Lamnisos, Janos Balega, Angela F. Brady, Aarti Sharma, Louise Izatt, Anjana Kulkarni, Vishakha Tripathi, Joyce S. Solomons, Kevin Hayes, Helen Hanson, Katie Snape, Lucy Side, Steve Skates, Alistair McGuire, Adam N. Rosenthal